EAY191-S3 | NCICIRB

Submitted by dcc on Mon, 2023-03-06 16:13

Study Title:

EAY191-S3, Phase II Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants with AKT-Altered Advanced Non-Breast Solid Tumors (A COMBOMATCH Treatment Trial)

CIRB:

Adult CIRB - Early Phase Emphasis

Lead Group:

ECOG

Status:

Active

Review Status:

Available to Open